Centricity Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$639K Sell
820
-3
-0.4% -$2.33K 0.51% 37
2025
Q1
$680K Sell
823
-3
-0.4% -$2.5K 0.62% 36
2024
Q4
$638K Buy
+826
New +$684K 0.6% 35

Other funds holding LLY

Centricity Wealth Management's LLY Position: Q2 2025 in Review

Centricity Wealth Management reduced its Eli Lilly (LLY) stake by 0.36% in Q2 2025, selling an estimated $2.33K and leaving 820 shares worth $639K. The position accounts for 0.51% of the portfolio, ranked #37.

Centricity Wealth Management first reported a position in LLY in Q4 2024 and has held it in 3 quarters since. The position peaked at $680K in Q1 2025. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Centricity Wealth Management held 820 shares of Eli Lilly worth $639K as of Q2 2025.
  • Centricity Wealth Management sold 3 Eli Lilly shares in Q2 2025, an estimated $2.33K.
  • Eli Lilly made up 0.51% of Centricity Wealth Management's portfolio in Q2 2025, its #37 holding.
  • Centricity Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 3 quarters since.
  • Centricity Wealth Management's Eli Lilly position peaked at $680K in Q1 2025.
  • 3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.